This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated FANCA Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-FANCA WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~162.8 kDa | |
| Gel | 8–10% (standard starting point) | |
| Negative control | Suggested KO / knockdown lysate |
| PTM | Phosphorylated | |
| Caveat | Phosphorylation-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 3 isoform(s) |
The M03662 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | A431 cell lysate (catalog M03662) |
| Gel % | 8–10% (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M03662; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
FANCA's predicted mass is 162.8 kDa; its isoforms could affect band patterns, but no empirical migration or distinct isoform bands are established.
| Band near 162.8 kDa | Consistent with the predicted FANCA mass; identity needs confirmation |
| Several bands at different positions | Could include isoforms 1, 2, and 3; their migration is not established |
| Band in nuclear fraction | Consistent with FANCA's major nuclear localization |
| Band in cytoplasmic fraction | Consistent with FANCA's minor cytoplasmic localization |
| Predicted FANCA mass | 162.8 kDa provides a reference size, not a measured migration |
| Isoform 1 | Relative size and migration are not supplied |
| Isoform 2 | May differ in size from other isoforms; relative size is unknown |
| Isoform 3 | May differ in size from other isoforms; relative size is unknown |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | FANCA is predominantly nuclear and may be poorly recovered | Check extraction and compare a nuclear fraction with loading controls |
| Band higher than expected | Identity or migration of the band is unverified | Confirm with an independent antibody or FANCA-deficient control |
| Band lower than expected | An alternative isoform is possible, but its size is unknown | Compare with a FANCA-deficient control and check isoform coverage |
| Multiple bands | Isoforms 1, 2, and 3 are listed, but distinct bands are unproven | Test band identity with a FANCA-deficient control |
| Weak or no signal | The major FANCA form is nuclear | Check nuclear extraction and sample loading |
| Fragments below expected size | Fragment identities are not established by the supplied features | Check sample integrity and confirm bands with a FANCA-deficient control |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No high/medium HPA tissues identified in the supplied evidence. | ||||
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| No lower-expression tissue rows available in the supplied evidence. | ||||
Deeper troubleshooting and optimisation questions for FANCA, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-FANCA antibody: M03662, a rabbit monoclonal with reported human reactivity. Its Western blot image shows FANCA expression in A431 cell lysate; the supplied evidence does not establish performance in other samples.
Which to pick: M03662 is the only listed option. Choose it for a human FANCA Western blot when the A431 cell lysate example is relevant; check suitability for other sample types separately.